ARYA Sciences Acquisition Corp IV (ARYD)
- Previous Close
11.37 - Open
11.37 - Bid --
- Ask --
- Day's Range
11.37 - 11.37 - 52 Week Range
10.44 - 11.39 - Volume
250 - Avg. Volume
18,677 - Market Cap (intraday)
85.69M - Beta (5Y Monthly) -0.01
- PE Ratio (TTM)
-- - EPS (TTM)
-0.22 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Arya Sciences Acquisition Corp IV does not have significant operations. The company intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. It focuses on acquiring North American or European companies in the life sciences and medical technology sectors. The company was incorporated in 2020 and is based in New York, New York.
www.perceptivelife.com/arya4--
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: ARYD
Performance Overview: ARYD
Trailing total returns as of 5/14/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: ARYD
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: ARYD
Valuation Measures
Market Cap
85.69M
Enterprise Value
87.84M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
--
Price/Book (mrq)
3.34
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-3.09%
Return on Equity (ttm)
--
Revenue (ttm)
--
Net Income Avi to Common (ttm)
-2.13M
Diluted EPS (ttm)
-0.22
Balance Sheet and Cash Flow
Total Cash (mrq)
20.19k
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
1.06M
Research Analysis: ARYD
Company Insights: ARYD
ARYD does not have Company Insights